Condition: Heart Failure With Reduced Ejection Fraction · Sponsor: Ceryx Medical Australia
The goal of this clinical trial is to test a new type of pacemaker in heart failure patients following a heart bypass operation. The new pacemaker restores respiratory sinus arrhythmia which is a natural pattern where the heart rate increases when the participants breathe in and slows down when participants breathe out. The main questions the trial aims to answer are: * Is the new type of pacemaker safe? * Does the new type of pacemaker improve how patients' hearts work (also known as cardiac output)? Participants will have a range of tests before their operation and during their recovery in hospital while participants have the new type of pacemaker in place, and will be monitored very closely. Participants will also receive a phone call 1 month after their surgery. Researchers will compare the new type of heart pacing against standard treatment to see if it is as safe, and if it is any better for patients.
This description comes directly from the study's public registry record.
Flora Yuen, BSc · +61 438 890 650 · flora.yuen@avaniaclinical.com
Melissa Crowne, BSc · +61 408270827 · melissa.crowne@avaniaclinical.com
Always discuss trial participation with your own doctor first.
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | Recruiting |
| Monash Health | Melbourne, Victoria, Australia | Recruiting |
| Waikato Hospital | Hamilton, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06384963